Market Cap (In INR)
45.46 Billion
Revenue (In INR)
13.69 Billion
Net Income (In INR)
-358.69 Million
Avg. Volume
218.48 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 91.85-240.9
- PE
- -
- EPS
- -
- Beta Value
- 0.816
- ISIN
- INE807F01027
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Rajaram Narayanan
- Employee Count
- -
- Website
- https://www.sequent.in
- Ipo Date
- Details
- Sequent Scientific Limited operates animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
More Stocks
-
DOSEFDoseology Sciences Inc.
DOSEF
-
EDENEden Research plc
EDEN
-
ORDSOoredoo Q.P.S.C.
ORDS
-
FOG
-
WBS
-
EXPL
-
5237Nozawa Corporation
5237
-
600977China Film Co.,Ltd.
600977